In addition to its effect on constitutive TLR3, Wnt5a levels and subsequent IL-6 production and STAT3 levels/activation, we then evaluated the ability of C10 to inhibit the migration and viability/growth of MCF-7 breast cancer cells. The gene discussed is STAT3; the disease is breast cancer.